Science Publications

Sign Up
Sign In
Submit
World Journal of Cancer and Oncology Research
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. World Journal of Cancer and Oncology Research
  4. Archive
  5. Volume 2, Issue 1, 2023
  6. Article
Review Article Open Access November 01, 2023

Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology

Shivankar Patra 1,*
1
Jamia Hamdard University, India
Publihed in: World Journal of Cancer and Oncology Research (Volume 2, Issue 1, 2023)
Page(s): 47-53
DOI: 10.31586/ujpp.2023.815
Received
September 29, 2023
Revised
October 28, 2023
Accepted
October 31, 2023
Published
November 01, 2023
Keywords
Drug Traceability; Drug Counterfeit; Pharmaceutical Serialization; Distributed Ledger Technology; Supply chain; Blockchain; Track and Trace System
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2023. Published by Scientific Publications
Article metrics
Views
374
Downloads
134

Cite This Article

APA Style
Patra, S. (2023). Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology. World Journal of Cancer and Oncology Research, 2(1), 47-53. https://doi.org/10.31586/ujpp.2023.815
ACS Style
Patra, S. Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology. World Journal of Cancer and Oncology Research 2023 2(1), 47-53. https://doi.org/10.31586/ujpp.2023.815
Chicago/Turabian Style
Patra, Shivankar. 2023. "Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology". World Journal of Cancer and Oncology Research 2, no. 1: 47-53. https://doi.org/10.31586/ujpp.2023.815
AMA Style
Patra S. Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology. World Journal of Cancer and Oncology Research. 2023; 2(1):47-53. https://doi.org/10.31586/ujpp.2023.815 
@Article{wjcor815,
AUTHOR = {Patra, Shivankar},
TITLE = {Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology},
JOURNAL = {World Journal of Cancer and Oncology Research},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {47-53},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/815},
ISSN = {2836-3981},
DOI = {10.31586/ujpp.2023.815},
ABSTRACT = {Currently, Drug Counterfeiting is the biggest challenge facing the pharmaceutical industry. They are encountering this threat due to high market demand for the drugs and their profit margin. The lack of data transparency and traceability also lured criminals into the counterfeiting of drugs which, is impacting people’s health and put their life in danger. Through the drug supply chain, a substantial portion of counterfeit drugs are injected and distributed through the healthcare supply chain network, so the supply chain plays a vital role in drug distribution and impacts patient lives. Through digitalization in the healthcare sector, Distributed Ledger Technology (DLT) provides a platform with ground-breaking results by providing a system for drug traceability with consideration of the critical requirements of transparency, privacy, and authenticity without involving any third party. In DLT, each distribution partner is registered to maintain transparency with the drug information. Real-time transfer of information about the change of ownership with date and time in the form of blocks gives visibility to all the partners in real time about the authenticity of drugs. This article will give information about the benefits of Distributed Ledger Technology to the pharmaceutical industry and the traceability of drugs from end-to-end of the pharmaceutical supply chain.},
}
%0 Journal Article
%A Patra, Shivankar
%D 2023
%J World Journal of Cancer and Oncology Research

%@ 2836-3981
%V 2
%N 1
%P 47-53

%T Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology
%M doi:10.31586/ujpp.2023.815
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/815

TY  - JOUR
AU  - Patra, Shivankar
TI  - Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology
T2  - World Journal of Cancer and Oncology Research
PY  - 2023
VL  - 2
IS  - 1
SN  - 2836-3981
SP  - 47
EP  - 53
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/815
AB  - Currently, Drug Counterfeiting is the biggest challenge facing the pharmaceutical industry. They are encountering this threat due to high market demand for the drugs and their profit margin. The lack of data transparency and traceability also lured criminals into the counterfeiting of drugs which, is impacting people’s health and put their life in danger. Through the drug supply chain, a substantial portion of counterfeit drugs are injected and distributed through the healthcare supply chain network, so the supply chain plays a vital role in drug distribution and impacts patient lives. Through digitalization in the healthcare sector, Distributed Ledger Technology (DLT) provides a platform with ground-breaking results by providing a system for drug traceability with consideration of the critical requirements of transparency, privacy, and authenticity without involving any third party. In DLT, each distribution partner is registered to maintain transparency with the drug information. Real-time transfer of information about the change of ownership with date and time in the form of blocks gives visibility to all the partners in real time about the authenticity of drugs. This article will give information about the benefits of Distributed Ledger Technology to the pharmaceutical industry and the traceability of drugs from end-to-end of the pharmaceutical supply chain.
DO  - Serialized Drug Traceability in the Supply Chain Using Distributed Ledger Technology
TI  - 10.31586/ujpp.2023.815
ER  -